Spots Global Cancer Trial Database for Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma
Official Title: A Phase 3b, Multicenter, Open-label, Single-arm, Expanded Access Protocol of Talimogene Laherparepvec for the Treatment of Subjects With Unresected, Stage lllB to IVM1c Melanoma
Study ID: NCT02147951
Conditions
Interventions
Study Description
Brief Summary: Expanded access of Talimogene Laherparepvec for subjects with unresected, stage IIIb to IVM1c Melanoma.
Detailed Description: Expanded access of Talimogene Laherparepvec for subjects with unresected, stage IIIb to IVM1c Melanoma that may not meet the eligibility criteria to enroll in another ongoing Talimogene Laherparepvec study or do not have access to enroll in an ongoing Talimogene Laherparepvec study.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Research Site, Mobile, Alabama, United States
Research Site, Mobile, Alabama, United States
Research Site, Little Rock, Arkansas, United States
Research Site, Duarte, California, United States
Research Site, La Jolla, California, United States
Research Site, Daytona Beach, Florida, United States
Research Site, Jacksonville, Florida, United States
Research Site, Miami Beach, Florida, United States
Research Site, Indianapolis, Indiana, United States
Research Site, Louisville, Kentucky, United States
Research Site, Minneapolis, Minnesota, United States
Research Site, St. Louis, Missouri, United States
Research Site, Omaha, Nebraska, United States
Research Site, Omaha, Nebraska, United States
Research Site, Morristown, New Jersey, United States
Research Site, New York, New York, United States
Research Site, Winston Salem, North Carolina, United States
Research Site, Canton, Ohio, United States
Research Site, Portland, Oregon, United States
Research Site, Greenville, South Carolina, United States
Research Site, Dallas, Texas, United States
Research Site, Dallas, Texas, United States
Research Site, Franklin, Wisconsin, United States
Research Site, Wauwatosa, Wisconsin, United States
Contact Details
Name: MD
Affiliation: Amgen
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
